A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT00061529 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Open-Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Brimonidine Tartrate Ophthalmic Solution

Sponsor

Alcon Research